These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 6371303)

  • 1. [Blood substitutes].
    Tomoda H
    Nihon Rinsho; 1983 Dec; 41(12):2803-9. PubMed ID: 6371303
    [No Abstract]   [Full Text] [Related]  

  • 2. Local oxygen supply of the myocardium after extreme hemodilution with Fluosol-DA.
    Kessler M; Vogel H; Günther H; Harrison DK; Höper J
    Prog Clin Biol Res; 1983; 122():237-48. PubMed ID: 6878366
    [No Abstract]   [Full Text] [Related]  

  • 3. Hemodilution and myocardial oxygen supply. The influence of fluosol-DA.
    Vogel H; Günther H; Harrison DK; Anderer W; Kessler M; Peter K
    Adv Exp Med Biol; 1989; 248():653-61. PubMed ID: 2782181
    [No Abstract]   [Full Text] [Related]  

  • 4. Fundamental and clinical studies on intracadaveric organ perfusion with Fluosol-DA.
    Honda K
    Prog Clin Biol Res; 1983; 122():327-30. PubMed ID: 6348786
    [No Abstract]   [Full Text] [Related]  

  • 5. [A comparative study of the effects of hemodilution with dextran and fluorocarbon emulsion on the changes in blood viscosity and collateral flow during myocardial ischemia].
    Ma XL; Zhao RR; Zang YM; Wang FZ
    Yao Xue Xue Bao; 1987 Sep; 22(9):641-4. PubMed ID: 2451396
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of fluosol-DA, an artificial blood, on the osmotic fragility of erythrocytes (author's transl)].
    Nogami T; Tsuno K; Yamashiro K; Terasaki H
    Masui; 1980 Nov; 29(12):1495-502. PubMed ID: 7463709
    [No Abstract]   [Full Text] [Related]  

  • 7. The effects of myocardial perfusion with perfluorochemical substances.
    Tomoda H
    Jpn Heart J; 1985 Mar; 26(2):247-57. PubMed ID: 4009968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Influences of Fluosol-DA infusion on the complement activation and on the blood level of histamine in man].
    Fukushima K; Nakamura M; Hinuma K
    Masui; 1983 Feb; 32(2):192-8. PubMed ID: 6854932
    [No Abstract]   [Full Text] [Related]  

  • 9. [Evaluation of potentials in using fluorocarbon cardioplegia for protecting the myocardium against ischemia].
    Beloiartsev FF; Kaĭdash AN; Islamov BI; Maevskiĭ EI; Kokoz IuM
    Vestn Akad Med Nauk SSSR; 1986; (6):37-43. PubMed ID: 3751261
    [No Abstract]   [Full Text] [Related]  

  • 10. [Evaluation of the protective effects on the ischemic myocardium of coronary perfusion with perfluorochemicals (fluosol-DA)--a comparison with cold blood cardioplegia].
    Ishimaru S; Hirayama T; Uchino T; Hakoshima A; Hino H; Yamada M; Koike S; Furukawa K; Takahashi M; Yoshihama I
    Nihon Kyobu Geka Gakkai Zasshi; 1986 Jan; 34(1):62-8. PubMed ID: 3711703
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effects of FDA 20 infusion on endocrine function in surgical patients (author's transl)].
    Matsuki A; Tanioka F; Miyahara T; Nagao H; Kudo T; Oyama T
    Masui; 1982 Mar; 31(3):235-9. PubMed ID: 7109218
    [No Abstract]   [Full Text] [Related]  

  • 12. Collateral oxygenation of the ischemic myocardium: the effect of viscosity and oxygen carrying fluorocarbons.
    Faithfull NS; Fennema M; Essed CE; Erdmann W; Jeekel H; Lapin R
    Prog Clin Biol Res; 1983; 122():229-36. PubMed ID: 6878365
    [No Abstract]   [Full Text] [Related]  

  • 13. Physiological effects of a perfluorochemical blood substitute in beagle dogs.
    Hoke JF; Ravis WR; Hankes GH; Spano J
    Res Commun Chem Pathol Pharmacol; 1991 Sep; 73(3):315-32. PubMed ID: 1719593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood substitutes: has the right solution been found?
    Lancet; 1986 Mar; 1(8483):717-8. PubMed ID: 2870227
    [No Abstract]   [Full Text] [Related]  

  • 15. Oxygen transport in vivo by means of perfluorochemical preparations.
    Geyer RP
    N Engl J Med; 1982 Jul; 307(5):304-5. PubMed ID: 6806660
    [No Abstract]   [Full Text] [Related]  

  • 16. [Morphology of the pig liver after Fluosol infusion].
    Petutschnigk D; Herrmann M; Hirlinger WK
    Z Mikrosk Anat Forsch; 1980; 94(5):908-12. PubMed ID: 7210801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of different oxygen concentrations during hemodilution with Fluosol or LMW-Dextran in rabbits.
    Beisbarth H; Madjidi A; Frey R
    Prog Clin Biol Res; 1983; 122():373-80. PubMed ID: 6192450
    [No Abstract]   [Full Text] [Related]  

  • 18. Failure to determine heparin concentrations in plasma containing Fluosol-DA using an analytical kit.
    Shrewsbury RP; White LG
    Clin Chim Acta; 1989 Feb; 179(3):347-8. PubMed ID: 2714008
    [No Abstract]   [Full Text] [Related]  

  • 19. [Long term effects of intravenous infusion of fluorocarbon blood substitute in dogs].
    Ding XC; Wang BS; Tang QN; Wang GF; Qin YQ; Liu YL
    Zhongguo Yao Li Xue Bao; 1985 Dec; 6(4):270-3. PubMed ID: 2945371
    [No Abstract]   [Full Text] [Related]  

  • 20. [Improvement of cardiac systolic function in myocardial ischemic rabbit by hemodilution with fluorocarbon emulsion].
    Ma XL; Zhao RR; Zang YM; Wang FZ
    Zhongguo Yao Li Xue Bao; 1988 Jan; 9(1):73-6. PubMed ID: 3188939
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.